{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:42:29Z","timestamp":1762659749648,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["836012001"],"award-info":[{"award-number":["836012001"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.reprotox.2019.01.002","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T02:19:54Z","timestamp":1546568394000},"page":"93-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Assessment of medication use during pregnancy by Web-based questionnaires, pharmacy records and serum screening"],"prefix":"10.1016","volume":"84","author":[{"given":"Marleen M.H.J.","family":"van Gelder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutea A.A.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernke","family":"te Winkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik J.H.","family":"Olyslager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Vorstenbosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eug\u00e8ne P.","family":"van Puijenbroek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 L.M.","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nel","family":"Roeleveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2019.01.002_bib0005","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ajog.2005.02.100","article-title":"Use of over-the-counter medications during pregnancy","volume":"193","author":"Werler","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1471-0528.2006.00927.x","article-title":"Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands","volume":"113","author":"Bakker","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.reprotox.2019.01.002_bib0015","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2125.2008.03102.x","article-title":"Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006","volume":"65","author":"Engeland","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ajog.2011.02.029","article-title":"Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008","volume":"205","author":"Mitchell","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004365","article-title":"Medication use in pregnancy: a cross-sectional, multinational web-based study","volume":"4","author":"Lupattelli","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.reprotox.2019.01.002_bib0030","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/AOG.0000000000000982","article-title":"The most commonly dispensed prescription medications among pregnant women enrolled in the US Medicaid program","volume":"126","author":"Palmsten","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128312","article-title":"Trends and determinants of prescription drug use during pregnancy and postpartum in British Columbia, 2002-2011: a population-based cohort study","volume":"10","author":"Smolina","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.reprotox.2019.01.002_bib0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajmg.c.30313","article-title":"Evolving knowledge of the teratogenicity of medications in human pregnancy","volume":"157","author":"Adam","year":"2011","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0045","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/pds.3495","article-title":"Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk","volume":"22","author":"Thorpe","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/humrep\/det370","article-title":"Drugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risks","volume":"29","author":"Van Gelder","year":"2014","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0055","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/oxfordjournals.aje.a116185","article-title":"Validation of a questionnaire on medical drug use during pregnancy","volume":"134","author":"De Jong","year":"1991","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00315343","article-title":"Drug use in pregnancy: a comparative appraisal of data collecting methods","volume":"45","author":"De Jong-van den Berg","year":"1993","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0065","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1471-0528.2008.01701.x","article-title":"Maternal depression and medication exposure during pregnancy: comparison of maternal retrospective recall to prospective documentation","volume":"115","author":"Newport","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.reprotox.2019.01.002_bib0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/bdra.22888","article-title":"Agreement between self-report and prescription data in medical records for pregnant women","volume":"94","author":"Sarangarm","year":"2012","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40264-012-0004-8","article-title":"Maternal recall of prescription medication use during pregnancy using a paper-based questionnaire: a validation study in the Netherlands","volume":"36","author":"Van Gelder","year":"2013","journal-title":"Drug Saf."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0080","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12884-015-0745-3","article-title":"Medication use during pregnancy, gestational age and date of delivery: agreement between maternal self-reports and health database information in a cohort","volume":"15","author":"Pisa","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.reprotox.2019.01.002_bib0085","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.annepidem.2016.11.015","article-title":"Validation of maternal recall of early pregnancy medication exposure using prospective diary data","volume":"27","author":"Sundermann","year":"2017","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0090","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/aje\/kwx239","article-title":"Using web-based questionnaires to assess medication use during pregnancy: a validation study in 2 prospectively enrolled cohorts","volume":"187","author":"Van Gelder","year":"2018","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0095","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s40471-017-0104-1","article-title":"Administrative claims data versus augmented pregnancy data for the study of pharmaceutical treatments in pregnancy","volume":"4","author":"Andrade","year":"2017","journal-title":"Curr. Epidemiol. Rep."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0100","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/bdra.20694","article-title":"Maternal-infant biomonitoring of environmental chemicals: the epidemiologic challenges","volume":"88","author":"Arbuckle","year":"2010","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0105","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/dta.1767","article-title":"Monitoring of drug intake during pregnancy by questionnaires and LC-MS\/MS drug urine screening: evaluation of both monitoring methods","volume":"7","author":"Hoeke","year":"2015","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0110","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/pds.3943","article-title":"Assessment of maternal drug intake by urinary bio monitoring during pregnancy and postpartally until the third perinatal year","volume":"25","author":"Hoeke","year":"2016","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0115","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00228-017-2402-4","article-title":"Drug use in pregnant women-a pilot study of the coherence between reported use of drugs and presence of drugs in plasma","volume":"74","author":"Wolgast","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/ppe.12023","article-title":"Rationale and design of the PRegnancy and Infant DEvelopment (PRIDE) Study","volume":"27","author":"Van Gelder","year":"2013","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0125","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/oxfordjournals.aje.a114286","article-title":"Effect of questionnaire design on recall of drug exposure in pregnancy","volume":"123","author":"Mitchell","year":"1986","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0895-4356(99)00167-5","article-title":"Influence of question structure on the recall of self-reported drug use","volume":"53","author":"Klungel","year":"2000","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0135","series-title":"Pharmacolepidemiology","first-page":"311","article-title":"Automated pharmacy records linkage in the Netherlands","author":"Leufkens","year":"2005"},{"key":"10.1016\/j.reprotox.2019.01.002_bib0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0378-4347(95)00267-2","article-title":"Determination of loratadine and pheniramine from human serum by gas chromatography-mass spectrometry","volume":"673","author":"Martens","year":"1995","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0145","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s002280050407","article-title":"Pharmacokinetic and harmacodynamics evaluation of fluticasone propionate after inhaled administration","volume":"53","author":"M\u00f6llmann","year":"1998","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0150","doi-asserted-by":"crossref","first-page":"e4194","DOI":"10.1002\/bmc.4194","article-title":"Quantification of acyclovir in dermal interstitial fluid and human serum by ultra-high-performance liquid-high-resolution tandem mass spectrometry for topical bioequivalence evaluation","volume":"32","author":"Schimek","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0155","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00216-007-1228-9","article-title":"Bioanalytical procedures for monitoring in utero drug exposure","volume":"388","author":"Gray","year":"2007","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.reprotox.2019.01.002_bib0160","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/ppe.12431","article-title":"How to improve information on medication exposure during pregnancy","volume":"32","author":"Stephansson","year":"2018","journal-title":"Paediatr. Perinat. Epidemiol."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623818304970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623818304970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:50:14Z","timestamp":1760190614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623818304970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":32,"alternative-id":["S0890623818304970"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2019.01.002","relation":{},"ISSN":["0890-6238"],"issn-type":[{"type":"print","value":"0890-6238"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of medication use during pregnancy by Web-based questionnaires, pharmacy records and serum screening","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2019.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}